Cancer cells become cancer cure
Researchers found that when they turned cancer cells into immune cells, they were able to teach other immune cells how to attack cancer.
Hemorrhage toolkit is cost-effective
A statewide quality-improvement project to treat excessive bleeding during childbirth averts $9 million annually in California’s health care costs, a Stanford Medicine-led study found.
Cyclotron director dies at 43
The director of the Stanford Medicine cyclotron and radiochemistry facility died on Jan. 25. He created novel radiotracers for clinical and research use.
African-American Alzheimer’s risk factor
A genetic risk factor found virtually exclusively among people of at least partial African ancestry substantially boosts the risk of incurring Alzheimer’s disease — but only sometimes.
Nobelist Paul Berg dies
Credited with sparking the field of genetic engineering, Stanford Medicine biochemist Paul Berg shared the 1980 Nobel Prize in chemistry for creating the first recombinant DNA molecule.
Mice have mirror neurons tuned to rage
When mice watch other mice brawl, neurons in their brains fire as if they’re in the fight, according to a new study by Stanford Medicine researchers.
Predicting prematurity complications
Stanford Medicine scientists and their colleagues have shown they can tap mothers’ and babies’ medical records to better predict newborn health risks.
One-and-done COVID-19 drug successful
A single dose of lambda-interferon reduced hospitalization among COVID-19 outpatients in a late-stage study spearheaded by a Stanford Medicine virologist.
Celiac expert Gary Gray dies at 89
Gastroenterologist Gary Gray, part of Stanford Medicine for nearly 50 years, helped find the molecular cause of celiac disease and a potential treatment.
Race linked to child abuse reports
Over-reporting of Black children and under-reporting of white children as suspected abuse victims suggests systemic bias from medical providers, Stanford Medicine research shows.